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Summary
Tks5/Fish is a scaffolding protein with five SH3 domains and one PX domain. In Src-transformed cells, Tks5/Fish localizes
to podosomes, discrete protrusions of the ventral membrane. We generated Src-transformed cells with reduced Tks5/
Fish levels. They no longer formed podosomes, did not degrade gelatin, and were poorly invasive. We detected Tks5/Fish
expression in podosomes in invasive cancer cells, as well as in human breast cancer and melanoma samples. Tks5/Fish
expression was also required for protease-driven matrigel invasion in human cancer cells. Finally, coexpression of Tks5/
Fish and Src in epithelial cells resulted in the appearance of podosomes. Thus, Tks5/Fish appears to be required for
podosome formation, for degradation of the extracellular matrix, and for invasion of some cancer cells.S I G N I F I C A N C E
Podosomes, or invadopodia, were first described as electron-dense structures on the ventral surface of Src-transformed fibroblasts,
where they form the attachment points between cell and substratum. These structures are also found in normal cells such as osteo-
clasts and macrophages, and in some invasive cancer cells. Podosomes are thought to promote the invasive properties of cells,
by clustering proteases involved in extracellular matrix degradation. We have previously shown that the scaffolding protein and Src
substrate Tks5/Fish localizes to podosomes. We now show that Tks5/Fish is required for podosome formation, and for matrix degrada-
tion and invasion. These findings support a broader investigation of Tks5/Fish and its binding proteins both as markers of invasive
disease and as potential therapeutic targets.Introduction
To metastasize, tumor cells must invade into tissues and cross
tissue boundaries. For most cancer cells, this is thought to re-
quire two events: increased motility, and proteolytic degrada-
tion of the extracellular matrix (Chang and Werb, 2001; Friedl
and Wolf, 2003). The motility of cancer cells is driven by reorga-
nization of the cytoskeleton and of contacts between the cell
and the matrix. This involves many of the same proteins that
are required for normal cell motility, including members of the
Rho family of small GTPases, and actin-associated proteins
and regulators (Ridley et al., 2003). Degradation of the extracel-
lular matrix occurs via the concerted action of a number of
proteases, including matrix metalloproteases (MMPs), cathep-
sins, and serine proteases such as seprase and uPA (Chen,
1992; Bauvois, 2004). The secretion of these proteases by tu-
mor cells results in the generation of “migration tracks” in the
extracellular matrix, through which the cells can move. The rel-
evance of proteases to the invasive capacity of most tumor
cells is supported by in vitro assays where invasion is blocked
by protease inhibitors, as well as in mouse model systems
(Chang and Werb, 2001).
The transformation of rodent and chicken fibroblasts by acti-CANCER CELL : FEBRUARY 2005 · VOL. 7 · COPYRIGHT © 2005 ELSEVIERvated forms of the protein tyrosine kinase Src has long pro-
vided a model for studying the properties of cancer cells (Mar-
tin, 2001). Src-transformed cells are not only morphologically
transformed, but are also highly invasive. They constitutively
produce uPA and MMPs (Bell et al., 1990; Chen et al., 1991).
They can degrade thin films of extracellular matrix proteins
such as fibronectin, laminin, and collagen (Chen et al., 1984,
1985). And they also are able to invade through matrigel (a
mixture of basement membrane proteins) in a Boyden chamber
assay. How is the activation of these extracellular proteases
coordinated? Many studies have implicated specialized struc-
tures called podosomes, which are also often referred to as
rosettes or invadopodia. Podosomes were first described as
electron-dense protrusions of the ventral membrane of Src-
transformed cells (David-Pfeuty and Singer, 1980; Tarone et al.,
1985). They were subsequently shown to have a diameter of
approximately 0.4 m, to extend from the cell body into the
matrix layer, to be enriched in actin, to be highly dynamic struc-
tures with a turnover time in the order of minutes, and to cluster
membrane proteases (Chen, 1989, 1990). Following the dis-
covery of podosomes in Src-transformed cells, similar struc-
tures were identified in osteoclasts, macrophages, and den-
dritic cells, all terminally differentiated cells of the monocyteINC. DOI 10.1016/j.ccr.2005.01.006 155
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Aepfelbacher, 2003; Buccione et al., 2004). More recently, cer-
tain invasive human cancer cells, particularly breast cancers
and melanomas, were also shown to contain podosomes (Kelly
et al., 1994; Monsky et al., 1994; Bowden et al., 1999). The cell
types in which podosomes are found support the notion that
these structures are involved not just in cell motility, but also in
extracellular matrix degradation and invasiveness.
Podosomes are actin-rich structures, and contain many actin
regulatory proteins, such as WASp, Arp2/3, and the small G
proteins cdc42 or RhoA, as well as actin-associated proteins
such as gelsolin. Podosomes also contain proteins that are
commonly found in focal adhesions, such as focal adhesion
kinase (FAK), integrin receptors, paxillin, Src, and vinculin.
However, other proteins found in podosomes are not found in
focal adhesions. These include the actin-associated protein
cortactin, the GTPase dynamin, the proteases seprase and
MT1-MMP (also known as MMP14), and the scaffolding protein
Tks5/Fish (for review, see Linder and Aepfelbacher, 2003; Buc-
cione et al., 2004). Several studies have shown that actin turn-
over is important in the formation of podosomes in various cell
types. For example, WASp, Arp2/3, cdc42, RhoA, and gelsolin
are all required for podosome formation, as is dynamin (Linder
et al., 1999, 2000; Chellaiah et al., 2000a, 2000b; Ochoa et al.,
2000; Mizutani et al., 2002; Moreau et al., 2003; Berdeaux et
al., 2004). Furthermore, it was shown in a melanoma cell line
that efficient extracellular matrix degradation required the po-
dosomal localization of MT1-MMP (Nakahara et al., 1997). The
mechanisms by which podosome formation and function are
regulated are therefore of interest in the context of tumor me-
tastasis.
We recently used a novel Src substrate screening assay to
isolate a new scaffolding protein with an aminoterminal phox
homology (PX) domain, and five SH3 domains (Lock et al.,
1998). We originally called this protein Fish. However, because
of the difficulties associated with accessing the relevant litera-
ture and databases using the name Fish, we now propose to
revert to the original clone id name, Tks5. To avoid confusion
during this transition, we will refer to the protein as Tks5/Fish
throughout this manuscript.
We demonstrated that Tks5/Fish was cytoplasmic in normal
fibroblasts, but was relocalized to podosomes in cells trans-
formed by Src (Abram et al., 2003). The PX domain of Tks5/
Fish is both necessary and sufficient for podosome localiza-
tion. Like most, if not all, PX domains, the PX domain of Tks5/
Fish associates with phosphatidylinositol lipids, with prefer-
ence in vitro for PI 3-P and PI 3,4-P2. The podosomes of Src-
transformed cells are not enriched in PI 3-P (unpublished data),
suggesting that PI 3,4-P2 may be responsible for targeting
Tks5/Fish to podosomes, but this remains to be established.
The binding partners for most of the SH3 domains of Tks5/Fish
are yet to be uncovered. However, we have shown that the 5th
SH3 domain associates with members of the ADAMs family of
metalloproteases. Further analysis showed that as a conse-
quence of this interaction, ADAM12, which is usually associ-
ated with intracellular membranes in fibroblasts, is found in the
podosomes of Src-transformed cells (Abram et al., 2003).
We hypothesized that Tks5/Fish might be involved in the for-
mation and/or function of podosomes. Here, we describe the
results of experiments designed to test this hypothesis, in both
Src-transformed fibroblasts and in human cancer cells.156Results
Reduction of Tks5/Fish expression in Src-transformed
cells alters their morphology
We utilized short hairpin (sh) RNA technology to reduce the
level of Tks5/Fish in Src-transformed cells. We first tested the
ability of four short interfering (si) RNAs targeted to different
regions of the Tks5/Fish gene to reduce expression of Tks5/
Fish in fibroblasts. Two of these siRNAs, 1 and 4, were effective
(data not shown). We then went on to create shRNA expression
vectors containing these sequences, transfected them into
NIH3T3 (3T3) cells transformed with the activated cSrc allele
Y527F (Src3T3), selected several drug-resistant clones, and
then tested for Tks5/Fish expression by immunoblotting. Only
shRNA sequence 4 efficiently reduced the expression of Tks5/
Fish when expressed in this hairpin vector rather than as a
short RNA (data not shown). We chose three knockdown
clones that had reduced Tks5/Fish expression (4.20, 4.21, and
4.24), as well as three control clones that were drug selected
after transfection with a vector containing a control sequence
designed not to target murine sequences (C1, C2, and C3), for
further analysis. Immunoblotting confirmed an approximately
5-fold reduction in Tks5/Fish levels in the knockdown, but not
control, clones (Figure 1A, top). An irrelevant protein of approx-
imately the same size (the PDGF receptor) was unaffected by
the shRNA (data not shown), and all cells retained expression
of the activated Src that was used to transform them (Figure
1A, bottom). We also determined that the overall level of tyro-
sine phosphorylation was unchanged when compared to
Src3T3 cells (Figure 1B), as was the ability of the cells to
secrete the metalloproteases MMP2 and MMP9 (Figure 1C).
We noticed no obvious differences in the growth rates of the
control and knockdown clones (data not shown). Furthermore,
the knockdown clones were still able to form foci when cocult-
ured with normal fibroblasts, although we did notice that they
displayed a fusiform morphology, rather than the more rounded
appearance of the control clones (data not shown).
We next examined more closely the morphology of the
knockdown and control clones, by plating them onto cover-
slips and visualizing F actin with fluorescent phalloidin (Figure
2A). The control clones retained the morphology of the parental
Src3T3 cells, with few actin fibers and many podosomes. In
contrast, the knockdown clones were larger and flatter, with
some actin stress fibers, but few obvious podosomes. The
morphological changes observed were present in essentially
all cells in the population. Since only one of our shRNA vectors
efficiently reduced Tks5/Fish expression, we were concerned
that the differences we observed might be due to off-target
effects of the interfering RNA. We therefore wanted to test
whether the phenotypic differences observed could be re-
versed by reintroduction of the Tks5/Fish protein. We took ad-
vantage of the fact that only 15 of the 19 base pairs encom-
passing siRNA 4 are conserved in the human Tks5/Fish cDNA,
and that, as determined by transfection, the levels of the hu-
man Tks5/Fish protein were unaffected by siRNA 4 (data not
shown). We microinjected 4.20 cells with an expression vector
containing a cDNA encoding human Tks5/Fish, incubated the
cells for 24 hr, and then stained the cells with fluorescent phal-
loidin and with an antibody that recognizes Tks5/Fish. We ob-
served that all microinjected cells were replete with podo-
somes, compared to the uninjected cells in the same field,CANCER CELL : FEBRUARY 2005
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Fish expression
Parental NIH3T3 (3T3) and Src-transformed NIH3T3 (Src3T3) cells, as well as
control (C1, C2, and C3) and Tks5/Fish knockdown (4.20, 4.21, and 4.24)
clones were grown to the same density and lysed, and protein concentra-
tions determined and normalized. The comparative levels of Tks5/Fish and
Src (A) as well as total phosphotyrosine content (B) were determined by
immunoblot. In fibroblasts, Tks5/Fish presents as a closely spaced triplet of
bands, as shown. Conditioned media from cells grown to the same density
were collected and assayed for gelatinase activity by zymography (C).
Molecular weight markers are shown on the left side of each panel.CANCER CELL : FEBRUARY 2005Figure 2. The impact of Tks5/Fish protein on the morphology of Src-trans-
formed cells
A: F actin morphology was determined in control (C1, C2, and C3) and
Tks5/Fish knockdown (4.20, 4.21, and 4.24) clones 48 hr after plating on
glass coverslips, by fixation and staining with phalloidin.
B: Tks5/Fish knockdown 4.20 cells were plated on glass coverslips, then
microinjected with an expression vector encoding human Tks5/Fish (hTks5).
Twenty-four hours later, the cells were fixed and stained with antibodies to
Tks5/Fish to visualize the microinjected cells, and phalloidin to visualize F
actin. Tks5/Fish staining is in red, and F actin staining in green.
C: Parental Src3T3 cells and the Tks5/Fish knockdown clone 4.20 were
grown on glass coverslips, then fixed and stained with either phalloidin, or
antibodies specific for β1 integrin or FAK, as shown. For each Src3T3 cell
image, arrowheads mark the positions of two typical rosettes of podo-
somes.which retained their more flattened morphology (Figure 2B). We
therefore conclude that the Tks5/Fish protein is rate-limiting for
the formation of podosomes in Src3T3 cells.
We chose one knockdown (4.20) clone for further analysis,
comparing it to the Src3T3 cells. For each staining condition,
one representative cell is shown in Figure 2C. In the parental
cells, all of the F actin staining was concentrated in the podo-
somes, which were present in characteristic rosettes. In con-
trast, podosomes were not observed in the 4.20 cells. Instead,
actin stress fibers and cortical actin staining were observed.
Some of the peripheral actin appeared to be present in an “ar-
rowhead” type of configuration, similar to that found in focal
adhesions. To analyze this further, we stained cells with anti-
bodies to β1 integrin and FAK, proteins which are found in focal
adhesions in normal cells (Parsons, 2003). We found that a pro-
portion of these proteins were localized to podosomes in the
parental cells, consistent with the reports of others (Linder and
Aepfelbacher, 2003). In contrast, in the 4.20 cells, these pro-
teins were localized to discrete spots in the periphery, coinci-
dent with the concentrations of F actin (Figure 2C, and data
not shown), which may therefore represent focal adhesions.Src-transformed cells with reduced Tks5/Fish expression
show defects in matrix degradation and invasion
We next tested whether a reduction in the level of Tks5/Fish
protein influenced the ability of the cells to degrade extracellu-157
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in which cells are plated onto fluorescently labeled matrix pro-
teins (in this case FITC-gelatin), and degradation is assessed
microscopically (Bowden et al., 2001). In this assay, 3T3 cells
do not degrade the gelatin, whereas the Src3T3 efficiently de-
grade the matrix layer in discrete spots coincident with the
presence of podosomes, as described by others previously
(data not shown). We observed that the control clones retained
their ability to degrade gelatin, but the knockdown clones were
unable to degrade the matrix protein efficiently during the
course of this assay (Figure 3A). We next tested whether ex-
pression of human Tks5/Fish could rescue matrix degradation
(Figure 3B). We found areas of degradation underneath the
microinjected cells, but not around cells in another area of the
coverslip that was not microinjected. We conclude therefore
that matrix degradation requires Tks5/Fish.
In vitro, the invasive capacity of cells can be measured by
testing their ability to invade through a layer of matrigel placed
in a Boyden chamber. We next tested our clones in this assay
(Figure 3C). Src-transformed cells are markedly more invasive
than the parental fibroblasts from which they derive. All the
control clones retained this degree of invasiveness. However,
the Tks5/Fish knockdown clones behaved more like the 3T3
cells, and exhibited a marked reduction in invasive capacity.
We also tested the motility of the knockdown clones (Figure
3D). Only one clone showed a statistically significant reduction
in migration; the other two clones did not differ significantly
from the parental cells or from the control clones. These data
suggest that Tks5/Fish is not required for the enhanced motility
of Src-transformed cells.
From these experiments, we conclude that Tks5/Fish is re-
quired for the formation of podosomes, as well as for matrix
degradation and in vitro invasiveness.
Many human cancer cells express Tks5/Fish
Podosomes have been described in several human cancer cell
lines, particularly invasive breast carcinomas and melanomas,
and their presence has been correlated with invasiveness in
vitro (Monsky et al., 1994; Kelly et al., 1998; Bowden et al.,
1999). To determine whether Tks5/Fish might play a role in hu-
man cancer cells, we first measured the levels of Tks5/Fish
protein in a number of cancer cell lines (Figure 4A). We first
compared two poorly invasive breast cancers, T47D and
MCF7, with the more invasive lines Hs578t, MDA-MB-231, and
Bt549 (Thompson et al., 1992; Bowden et al., 1999). Tks5/Fish
was expressed at very low levels in T47D and MCF7 cells, visi-
ble only at longer exposures of the blot (data not shown), but
was more highly expressed in the invasive cells. All the mela-
noma cell lines we tested (including the RPMI-7951 and
C8161.9 lines used later, as well as several others, had Tks5/
Fish expression levels as high or higher than Bt549 cells; data
not shown). As in fibroblasts, Tks5/Fish is expressed in multiple
forms in these cells; it is possible, but remains to be estab-
lished, that alternative splicing and/or phosphorylation plays a
role in the generation of these different isoforms. Interestingly,
when we compared the levels of Tks5/Fish mRNA by RT-PCR,
we detected very low levels of mRNA in the T47D cells, but the
MCF7 cells contained approximately the same level of mRNA
as the invasive lines (Figure 4B), suggesting that Tks5/Fish ex-
pression is likely to be controlled at both the RNA and the pro-
tein level.158Figure 3. Analysis of the invasive capacity of control and Tks5/Fish knock-
down cells
A: Control (C1, C2, and C3) and Tks5/Fish knockdown (4.20, 4.21, and 4.24)
clones were tested over a period of 48 hr for the ability to degrade a thin
layer of FITC-gelatin coated onto glass coverslips. Degradation is indicated
by the dark patches (holes) within the fluorescent monolayer. Cell density
is indicated by Hoechst staining of nuclei (blue).
B: Tks5/Fish knockdown 4.20 cells were plated on FITC-gelatin coated glass
coverslips, then microinjected with an expression vector encoding human
Tks5/Fish (hTks5). Twenty-four hours later, the cells were fixed and stained
with antibodies to Tks5/Fish to visualize the microinjected cells (not shown),
and Hoechst to visualize nuclei (blue). The top panel shows three microin-
jected cells and surrounding patches of gelatin degradation. The bottom
panel shows a region of the coverslip containing uninjected (uninj) cells.
C: 3T3 and Src3T3, along with control (C1, C2, and C3) and Tks5/Fish knock-
down (4.20, 4.21, and 4.24) clones, were tested for their ability to invade
through a thin layer of matrigel in a Boyden chamber assay over a period
of 24 hr. The data were compiled from three independent experiments. All
measurements were calculated as percent of control (Src3T3) and error
bars calculated as propagated standard errors of the mean of triplicate
measurements from each experiment. Statistical significance was deter-
mined by paired t tests with an asterisk indicating a statistical difference
from the control (p < 0.05).
D: 3T3 and Src3T3, along with control (C1, C2, and C3) and Tks5/Fish knock-
down (4.20, 4.21, and 4.24) clones, were tested for migration in a Boyden
chamber assay over a period of 24 hr. Data were plotted and analyzed
as described in C.CANCER CELL : FEBRUARY 2005
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lines, and in tumor samples
A: Whole-cell lysates derived from the indicated breast carcinoma cell
lines were normalized for protein concentration, then immunoprecipitated
and immunoblotted with a Tks5/Fish antibody. Tks5/Fish is present as a
closely spaced series of bands, present in different ratios depending on
the cell line tested, as shown.
B: RT-PCR was used to make a semiquantitative comparison of Tks5/Fish
mRNA levels (upper band) across the indicated breast carcinoma cell
lines. The lower band is nonspecific.
C: Breast carcinoma cells were grown on glass coverslips for 48 hr, fixed,
and stained with antibodies for Tks5/Fish, and phalloidin to visualize F actin,
as shown. In each image, the localization of representative rosettes of po-
dosomes is marked by arrowheads.
D: The melanoma cell lines RPMI-7951 and C8161.9 were grown and pro-
cessed as described in C. Rosettes of podosomes are marked by arrow-
heads.We next determined whether Tks5/Fish was present in the
podosomes of human cancer cells (Figures 4C and 4D). We
should note that unlike Src-transformed fibroblasts, where po-
dosomes are found in the majority of cells, in our hands, only
a small percentage of the breast carcinoma and melanoma
cells have podosomes at any given time. However, we did find
that when we detected podosomes in both breast cancer cell
lines (Bt549 and MDA-MB-231) and melanomas (RPMI-7951
and C8161.9), Tks5/Fish appeared to be colocalized to these
structures, albeit it at very low levels.
To determine whether Tks5/Fish could also be detected in
human tumor samples, we first used immunohistochemistry to
visualize Tks5/Fish in samples of normal breast and breastCANCER CELL : FEBRUARY 2005Figure 5. The expression and localization of Tks5/Fish in human tumor
samples
Histological samples of normal and cancerous breast (A) and skin (B) tissue
were stained with Tks5/Fish antibodies or with hematoxylin and eosin (H&
E), as shown. The oval in B shows high levels of Tks5/Fish in invading tumor
cells. Background staining from the secondary antibody is also indicated
in B. DCIS, ductal carcinoma in situ.cancer (Figure 5A). We noted moderate Tks5/Fish expression
that was restricted to ductal cells in normal breast tissue. How-
ever, both ductal carcinoma in situ (DCIS) and metastatic
breast cancer samples showed extensive Tks5/Fish expression
in the malignant cells. No staining was observed with preim-
mune rabbit serum as the primary, and a second Tks5/Fish
antibody that recognizes a different epitope gave the same
staining pattern (data not shown). In total, we have analyzed
14 samples of human breast tissue (4 normal, 3 DCIS, 3 micro-
invasive, and 4 metastatic); all the precancerous and tumor
cells had higher Tks5/Fish staining than the surrounding nor-
mal tissue. We next went on to examine samples of skin tissue159
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basal layer, but higher staining in both an early stage mela-
noma and a metastatic tumor. Interestingly, there was particu-
larly intense staining in those melanoma cells that were invad-
ing into the surrounding tissue from the early stage melanoma
(middle panels). In total, we have analyzed 16 skin samples (4
normal, 7 with Breslow grading from 1–4 mm, and 4 meta-
static), and have always observed higher Tks5/Fish staining in
the tumors. We therefore conclude that Tks5/Fish is expressed
in human tumor cells in vivo.
Tks5/Fish is required for invasion of human cancer cells
These findings prompted us to test whether Tks5/Fish was re-
quired for invasiveness in human cancer cells. We first chose
one breast cancer cell line (Bt549) and one melanoma (RPMI-
7951) for our analyses. We transfected them with two indepen-
dent siRNAs targeting Tks5/Fish, or with a mixture of siRNAs
designed to not reduce expression of cell proteins (duplex con-
trol). Reduction of all isoforms of Tks5/Fish with the specific
siRNAs was confirmed by immunoblot analysis (Figure 6A). We
next tested the ability of these cells to degrade thin films of
gelatin (Figure 6B), and found that in both cases, the Tks5/Fish
siRNA transfected cells showed reduced degradation com-
pared to controls. We viewed at least 25 fields, and counted
as positive all fields that contained any degradation, however
small. For both cell lines, essentially all fields of duplex control
transfected cells showed degradation. However, degradation
was only observed in 55% or fewer of all fields of Tks5/Fish
knockdown cells. Furthermore, even when degradation was
observed, it was much less extensive in the Tks5/Fish knock-
downs than in the controls (compare for example DC and si2
for RPMI-7951 in Figure 6B). We next tested the invasiveness
of the siRNA-transfected cells in a Boyden chamber assay
(Figure 6C). In each case, we noted a significant, but not abso-
lute, reduction in matrigel invasion in the cells with reduced
Tks5/Fish expression. No significant differences in motility
were observed. We also found a similar requirement for Tks5/
Fish for invasiveness of the other tumor cell lines (Figure 7). As
was the case for the Src-transformed cells with reduced Tks5/Figure 6. Generation and analysis of invasion in
human cancer cells with reduced Tks5/Fish ex-
pression
Two siRNAs (si1 and si2) targeting human Tks5/
Fish, or a pool of duplex controls (DC), were
transiently transfected into BT549 breast carci-
noma cells or RPMI-7951 melanoma cells. Thirty
hours posttransfection, the cells were either pro-
cessed for the measurement of Tks5/Fish protein
levels following immunoprecipitation of lysates
with a Tks5/Fish antibody (A), plated onto FITC-
gelatin coated glass coverslips to measure gel-
atin degradation activity (B), transferred to Boy-
den chambers to measure migration or invasion
through matrigel (C), or quiesced for 48 hr in or-
der to test the conditioned medium for gela-
tinase activity by zymography (D). The data in
each panel derive from separate transfections,
but in each case, immunoblotting was con-
ducted to ensure that Tks5/Fish levels were re-
duced by the siRNA treatment. The data in C
represent the mean of triplicate measurements (with propagated standard errors) expressed as a percentage of the duplex control treated cells from a
single, representative experiment. Asterisks represent a statistical difference from the control (p < 0.05).160mechanism might be in force in the cells we are studying, we
Figure 7. Tks5/Fish is required for protease-dependent invasion
siRNA-transfected breast carcinoma (BT549, MB-231, Hs578t) and mela-
noma (C8161.9, RPMI-7951) cells were transfected prior to invasion assays
as described in Figure 6, except that a cocktail of protease inhibitors (or
vehicle alone) were added to each experimental group of cells in order
to monitor the protease dependence of invasion through matrigel. The
invasion of each experimental group of cells is expressed as a percentage
of the duplex control-treated cells that lacked protease inhibitors in the
medium, and was analyzed as described in Figure 6. siTks5 refers to the use
of either siRNA2 alone (RPMI-7951; refer to Figure 6), a combination of
siRNA1 and 2 (BT549, MB-231), or a pool of siRNAs (Hs578T, C8161.9). All of
these conditions reduce Tks5/Fish protein levels.Fish expression, no significant differences in MMP secretion
were observed (Figure 6D). These data suggest that Tks5/Fish
is also required for optimal matrix degradation and invasive-
ness of human cancer cells.
It has recently been noted that cancer cells can penetrate
extracellular matrix either in a manner that requires proteases,
or using a protease-independent mechanism that, in some
cases at least, might be due to amoeboid-type movement (Sa-
hai and Marshall, 2003; Wolf et al., 2003). To determine whichCANCER CELL : FEBRUARY 2005
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of a cocktail of protease inhibitors that have previously been
shown to block proteolytic invasion (Sahai and Marshall, 2003).
We found that whereas the invasion of the duplex control-
treated cells could be partially blocked by the protease inhibi-
tors, little further reduction in invasion of the Tks5/Fish siRNA
treated cells was detected in the presence of protease inhibi-
tors (Figure 7). These data suggest that Tks5/Fish is required
for the protease-driven invasion of matrigel.
Expression of Tks5/Fish in T47D cells results
in the generation of podosomes
Our studies to date have determined that the Tks5/Fish protein
is required for the formation of podosomes. We next wanted
to determine whether introduction of Tks5/Fish into cells that
do not normally express it was sufficient to drive podosome
formation. We chose T47D cells, which have very low levels of
both Tks5/Fish mRNA and protein. When these cells were in-
jected with an expression vector encoding Tks5/Fish, some
morphological changes in the actin cytoskeleton were noted,
but no podosomes were observed (Figure 8). However, when
Tks5/Fish was coinjected with an activated form of Src, punc-
tate actin-rich structures containing Tks5/Fish were evident on
the ventral surface of the cell. No such structures were seen
when Src was expressed alone, although activated Src did
have profound effects on both morphology and the actin cy-
toskeleton. Consistent with our previous findings that the PX
domain of Tks5/Fish is required to target it to podosomes (Ab-
ram et al., 2003), when Tks5/FishPX and Src were coex-
pressed, no podosomes were observed. Interestingly, in the
presence of Tks5/FishPX, expression of activated Src did not
result in any gross morphological changes; rather, all actin po-
lymerization in the cell appeared to be inhibited. We conclude
that Tks5/Fish, when expressed in cells containing active Src,
is able to promote the formation of podosomes.
Discussion
Tks5/Fish is a large adaptor protein and Src substrate that we
have previously shown to be present in the podosomes of Src-
transformed cells (Abram et al., 2003). We have now used
shRNA technology to demonstrate that the Tks5/Fish proteinFigure 8. The generation of podosomes in T47D
cells
T47D cells were microinjected with the indi-
cated expression vectors encoding either wild-
type Tks5/Fish, Tks5/FishPX, and/or Src. Twenty-
four hours later, the cells were fixed and stained
with antibodies to Tks5/Fish or Src, and phalloidin
to visualize F actin, as indicated in each panel.CANCER CELL : FEBRUARY 2005is required for the formation of podosomes in Src-transformed
cells. In the absence of robust Tks5/Fish expression, Src-trans-
formed fibroblasts do not revert to an untransformed pheno-
type, but they do adopt a larger, flatter morphology, with some
normal actin cytoskeleton. In addition, while the parental Src-
transformed cells attach to the substratum via the podosomes,
the knockdown cells have ventral structures that resemble fo-
cal adhesions, containing integrins, FAK, and vinculin (Figure
2C and data not shown). This might suggest that, when pre-
sent, the Tks5/Fish protein recruits focal adhesion proteins
such as these, as well as cortical proteins such as cortactin,
into the podosomes.
Our data show that Tks5/Fish is required for podosome for-
mation. We also show that the introduction of Tks5/Fish (along
with activated Src) results in the formation of podosomes in
cells that do not normally have them. We have succeeded in
generating podosomes in T47D cells (Figure 8), as well as
MCF7 and 293 cells (data not shown), all epithelial cells with a
very low level of endogenous Tks5/Fish protein. We have pre-
viously shown that the PX domain of Tks5/Fish is required to
target the protein to preformed podosomes in Src-transformed
cells (Abram et al., 2003). In keeping with this, a Tks5/Fish pro-
tein lacking the PX domain was unable to promote podosome
formation when coinjected with activated Src into T47D cells.
The PX domain of Tks5/Fish is a phosphoinositide binding do-
main, with an apparent preference for PI3-P and PI3,4-P2. The
model that we are currently testing is that Tks5/Fish is first
recruited diffusely to membranes via the interaction of its PX
domain with a phosphatidylinositol lipid (perhaps PI3,4-P2),
and then a clustering of Tks5/Fish and its associated proteins
results in the formation of podosomes. Perhaps one of the
functions of activated Src in this assay is to (indirectly) gener-
ate the lipid product that recruits Tks5/Fish to the plasma
membrane. It is also possible that Tks5/Fish itself, as well as
other podosome proteins, need to be tyrosine phosphorylated
for podosome formation. Indeed, it has been observed pre-
viously that podosomes are enriched in tyrosine phosphory-
lated proteins (Mueller et al., 1992). The microinjection assay
we describe here will now allow us to dissect the roles of Src,
and the different domains of Tks5/Fish, in podosome formation.
Why is Tks5/Fish needed for podosome formation? One
model would be that it associates with, and thus recruits, pro-161
A R T I C L Eteins known to be required for podosome formation. In keeping
with this model, we have preliminary evidence that the 3rd SH3
domain of Tks5/Fish is able to associate with the actin regula-
tory protein N-WASp (unpublished data); N-WASp and the re-
lated protein WASp are essential for podosome formation in
Src-transformed fibroblasts and macrophages, respectively
(Linder et al., 1999; Mizutani et al., 2002).
Analysis of Src-transformed cells with reduced Tks5/Fish ex-
pression revealed that they are markedly handicapped in both
the ability to degrade a thin film of gelatin, and in invasion
through matrigel, both properties that are thought to involve
proteases, particularly matrix metalloproteases. In this regard,
it is interesting to note that the knockdown cells still secrete
MMP2 and MMP9, in both precursor and cleaved forms. At
this point, it is not clear why these secreted MMPs are not able
to degrade the extracellular matrix. Perhaps they are required
to be locally activated at podosomes to be functional. In keep-
ing with this, the podosome localization of MT1-MMP, an acti-
vator of MMP2 and MMP9, appears to be required for matrix
degradation (Nakahara et al., 1997).
Epithelial cells typically express low levels of the Tks5/Fish
protein. However, we have noted increased Tks5/Fish expres-
sion in many cancer cell lines, including invasive breast carci-
nomas (Figure 4) and melanomas (data not shown). This finding
was not restricted to cells in culture; we also noted marked
staining with Tks5/Fish antibodies in paraffin embedded tumor
samples (Figure 5). We are currently extending these analyses
to more cell lines and tissues, in order to address whether
Tks5/Fish levels may be predictive of invasive disease. This
would be particularly useful in melanoma, where there are few
markers of metastatic disease. One breast cancer cell line with
low Tks5/Fish levels (T47D) has barely detectable Tks5/Fish
mRNA, whereas the other (MCF7) has mRNA levels similar to
those in the invasive lines. These findings suggest that Tks5/
Fish is regulated at both the RNA and the protein level, and
that microarray analysis will not always be suitable to measure
Tks5/Fish levels in tumor samples. We have also observed that
the half-life of the Tks5/Fish protein is considerably longer in
Src-transformed cells than in their normal counterparts (unpub-
lished data), which might suggest that tyrosine phosphoryla-
tion, or podosomal localization, enhances its stability. More
work is clearly needed to determine how the level of the Tks5/
Fish protein is controlled.
Invasive breast cancer cells and melanomas such as those
used in this study have been previously reported to have podo-
somes (Kelly et al., 1994; Monsky et al., 1994; Bowden et al.,
1999). We have also observed podosomes in these cells, al-
though we find that in a given population of cells at a given
time, only the minority will have obvious podosomes. Perhaps
podosomes only form at a particular point in the cell cycle,
or in response to a particular signal. This has previously been
observed in cells of the macrophage/monocyte lineage. For ex-
ample, podosomes form in osteoclasts as they differentiate
(Destaing et al., 2003), and in dendritic cells as they initiate
migration in response to a stimulus such a lipopolysaccharide
(Burns et al., 2004). It is also known that podosomes have a
rapid turnover. In the future it will be important to determine
the signals that mediate the formation and turnover of podo-
somes of tumor cells; this control point might represent an
attractive target for therapeutic intervention. Regardless, in the
invasive breast cancer cells and melanomas where podosomes162were observed, we detected Tks5/Fish colocalization with the
structures, suggesting that Tks5/Fish is a common component
of podosomes.
To determine whether Tks5/Fish is also required for the inva-
sive properties of human cancer cells, we used transient trans-
fection of siRNAs, resulting in a reduction of Tks5/Fish expres-
sion of approximately 80%. We noticed a significant reduction
in the ability of such cells to invade matrigel, compared to du-
plex control cells. However, we noted that in each case, the
inhibition was not complete. Furthermore, invasion of the con-
trol cells was partially inhibited by treatment with a cocktail of
protease inhibitors, whereas the Tks5/Fish knockdown cells
were not further inhibited by the addition of protease inhibitors
to the assay. This suggests that some of the cells in the pop-
ulation can use a protease-independent method of invasion, as
recently described. Interestingly, it has been shown that when
proteolytic activity is inhibited, MDA-MB-231 cells use an
amoeboid movement to penetrate matrigel (Wolf et al., 2003).
Our data support the hypothesis that Tks5/Fish is required for
proteolytic invasion. It will be interesting to determine in the
future how many cancer cells use proteolytic mechanisms to
invade, and whether such an invasive strategy correlates with
the presence of podosomes in the cells.
In conclusion, we have shown that the adaptor protein and
Src substrate Tks5/Fish is required for podosome formation
and function in Src-transformed fibroblasts. Furthermore,
Tks5/Fish is overexpressed in some invasive human cancer
cells, and is required for proteolytic invasion. These findings
support a broader investigation of Tks5/Fish and its binding
proteins both as markers of invasive disease and as potential
therapeutic targets. Finally, we have developed a method to
form podosomes in cells that do not normally have them,
which will allow us in the future to dissect the signals and pro-
teins that regulate podosome formation and turnover.
Experimental procedures
Constructs
The mutant form of chicken Src with an activating Y527F substitution in
pSGT and the Tks5/Fish constructs have been previously described (Lock
et al., 1998; Abram et al., 2003). All plasmids were double purified over
cesium chloride gradients.
Cell lines
NIH3T3 and SrcY527F-transformed NIH3T3 (Src3T3) cells have been de-
scribed before (Lock et al., 1998). The breast carcinoma cell lines MCF-7,
Bt549, Hs578t, and MDA-MB-231 were generously provided by Dr. Han-Mo
Koo, Van Andel Institute. The C8161.9 melanoma cell line was generously
provided by Dr. Cindy Miranti, Van Andel Institute. T47D and RPMI-7951
cells were obtained from the ATCC. All cell lines were maintained in Du-
becco’s modified Eagle’s medium (DMEM; Invitrogen) containing 10% fetal
calf serum (HyClone) and antibiotics in 10% CO2.
Biochemical techniques
Our general procedures for cell lysis, immunoprecipitation, and immu-
noblotting have been described before, and are available on request.
Tks5/Fish knockdown cell lines
Src-transformed NIH3T3 cells with reduced levels of Tks5/Fish protein were
generated by shRNA technology. Briefly, commercially synthesized comple-
mentary primers (Integrated DNA Technologies) were designed to express
a short hairpin (sh) RNA for the direct targeting and knockdown of murine
Tks5/Fish mRNA sequences. These primers were annealed and the result-
ing construct ligated into pSilencer2.1U6hygro (Ambion) at the accessible
BamHI/HindIII restriction sites using standard subcloning techniques. Suc-CANCER CELL : FEBRUARY 2005
A R T I C L Ecessfully engineered plasmids were confirmed by restriction mapping and
by DNA sequencing in the presence of 5% DMSO. Two different shRNA-
expression constructs were tested based on previous success with the
knockdown of Tks5/Fish in cells transiently transfected with siRNA se-
quences. A control shRNA sequence (C) was also designed because it does







The complementary primer sequences are not shown; the siRNA se-
quences are underlined. shRNA-expression plasmids were introduced into
Src-transformed NIH3T3 cells using calcium phosphate. Drug-resistant col-
onies were selected in the presence of 100 g/ml hygromycin (Invitrogen)
supplemented into the culture medium. Drug-resistant cell lines were main-
tained in 100 g/ml hygromycin, except during experimentation.
Transient Tks5/Fish knockdown experiments
Breast carcinoma and melanoma cells were grown to 70% confluency un-
der standard growth conditions. Cells were washed into fresh culture me-
dium 1 hr prior to transfections and into Opti-MEM (Invitrogen) 30 min prior
to transfections. Two duplex siRNAs (sense strands: GCCAAAGCAAGGAC
GAGAU [si1] and AAACCAGUGGCGACCUGAA [si2]) directed against hu-
man Tks5/Fish (Dharmacon) were used either alone or in combination to
knockdown Tks/Fish protein. A “Smartpool” of four siRNAs (Dharmacon)
was also used to knockdown human Tks/Fish protein (none of these siRNAs
have the same sequence as si1 and si2 above). siRNAs were combined
with Lipofectamine 2000 (Invitrogen) according to manufacturer’s guidelines
and added to cells in Opti-MEM at a final concentration of 100 nM. Control
transfections consisted of a pool of four nontargeting siRNAs (duplex con-
trol, Dharmacon). Transfections were carried out for 3 hr at 37°C, after which
the transfection medium was replaced with fresh culture medium. Analysis
of Tks5/Fish protein levels, podosome formation, and transfer into invasion
assays were initiated 30 hr posttransfection.
Fluorescence microscopy
Cells were grown for a minimum of 48 hr postpassage on glass coverslips.
Cells were fixed in 3% formaldehyde (Electron Microscopy Sciences)/PBS
for 10 min, made permeable in 0.1% Triton X-100/PBS for 10 min, and
processed with various antibody applications and/or phalloidin in 5% don-
key serum (Jackson Immuno-Research Laboratories)/PBS. Primary detec-
tion reagents include antibodies for Tks5/Fish (Tks5/Fish.2 1736, 1:500),
Src (327), β1-integrin (N-20, 1:400; Santa Cruz), FAK (2A7, 1:200; Upstate
Biotechnology), and F actin (Alexa Fluor 488 and 594 phalloidin, 1:1000;
Molecular Probes). Secondary detection reagents include Alexa Fluor 488
and 594- and Texas Red-conjugated IgGs (1:2000; Molecular Probes). After
washing extensively in PBS, coverslips were mounted in 1 mg/ml p-phenyl-
ene diamine (Sigma) in 90% glycerol/PBS. Images were captured using an
Axioplan 2 fluorescent microscope and were analyzed with Axiovision 3.0
software (Zeiss).
ECM degradation assay
Fluorescein isothiocyanate (FITC)-labeled gelatin-coated coverslips were
prepared essentially as described before (Bowden et al., 2001) with some
modifications. Briefly, 2% gelatin (300 bloom; Sigma)/2% sucrose/PBS was
prelabeled with 0.2 mg/ml FITC (Fluka) in 50 mM sodium borate (Sigma),
40 mM sodium chloride (Sigma) (pH 9.3) before dialysis into PBS. A thin
layer of FITC-gelatin was coated onto glass coverslips and immediately
crosslinked with ice-cold 0.8% glutaraldehyde (Electron Microscopy Sci-
ences)/PBS for 15 min at 4°C and then for 30 min at room temperature.
Coverslips were successively washed in PBS (3 × 5 min), 5 mg/ml sodium
borate/PBS (1 × 3 min), PBS (3 × 5 min), and 70% ethanol (1 × 10 min),
before quenching for 1 hr with DMEM. Cells were cultured such that by
48 hr the coverslips were nearly confluent. Coverslips were subsequently
processed using standard fluorescence microscopy procedures.
Motility and Invasion assays
Matrigel-containing Boyden transwell chambers (BD Biosciences) were pre-
hydrated 6 hr prior to cell application with medium containing 0.1% fetalCANCER CELL : FEBRUARY 2005calf serum (FCS) placed in the insert chambers and with media containing
10% FCS in the lower chambers. Cells to be tested were detached from
cultures dishes in trypsin/EDTA (Invitrogen). This reaction was stopped by
a 2-fold dilution in 1 mg/ml soybean trypsin inhibitor/PBS (final concentra-
tion). Cells were sedimented at 1000 g for 5 min, suspended in 5 ml PBS,
resedimented, and finally suspended in 1 ml of the appropriate growth me-
dia containing 0.1% FCS. 25,000 cells (counted by automation; Beckman)
in 500 l of media containing 0.1% FCS were placed into each Boyden
chamber. The appropriate growth media containing 10% FCS (750 l) was
placed in the lower chamber to facilitate chemotaxis. Invasion assays were
run for 24 (for Src-transformed fibroblasts) or 48 hr (for human cancer cell
lines). Noninvading cells were removed from the insert chambers using cot-
ton swabs, then cells which passed through the matrigel membrane were
stained with 0.09% crystal violet/10% ethanol. After removing excess stain
by washing with deionized water, the stain was eluted with 200 l of elution
buffer (1 part acetate buffer [pH 4.5] : 2 parts ethanol : 1 part deionized water).
The optical density of 100 l of the eluted stain was measured at 570 nm
(96-well plate reader, Dynex Technologies). All assays were conducted in
triplicate. To study the effect of protease inhibitors on cell invasion, 25,000
cells were suspended in 500 l of appropriate media containing 0.1% FCS
and a cocktail of protease inhibitors, and were placed into each Boyden
chamber. The inhibitor cocktail consists of 10 mM calpeptin (03-34-0051;
Calbiochem), 20 mM GM6001 (364205; Calbiochem), 10 mg/ml aprotinin
(616370; Calbiochem), and 10 mg/ml leupeptin (108975; Calbiochem). Ap-
propriate media (750 l) containing 10% FCS and the same inhibitor cock-
tail was placed in the lower chamber. Measurement of invasion was done
as described above. Motility assays were conducted in Boyden transwell
chambers lacking matrigel over a period of 24 hr. Experimental conditions
and the processing of chambers were as described above.
Microinjection
Cells were grown to 50%–60% confluency on etched CellLocate glass cov-
erslips (Eppendorf). All injected DNA samples were adjusted to 100 g/ml,
except where indicated in the figure legend. DNA samples were microin-
jected into the nuclei of attached cells using either custom-pulled micropi-
pette needles (Flaming/Brown micropipette puller, Sutter Instrument) or pre-
pulled Femtotips needles (Eppendorf). Standardized injection parameters
were programmed into a Femtojet Micromanipulator 5171 (Brinkmann) ac-
cording to manufacturer’s guidelines and visualized with an Axiovert 200
inverted fluorescent microscope (Zeiss). To assay podosomes, the cells
were incubated 24 hr after injection and processed by standard fluores-
cence microscopy procedures.
Histochemistry
Slides containing thin sections of dewaxed human breast or skin tissue
were warmed in Coplin jars containing 10 mM sodium citrate (pH 6.5) for
20 min at 90°C before being allowed to cool back to room temperature.
With interspersed washes in PBS, all samples were prepped for antibody
application by successive 30 min treatments in 0.1% Triton-X 100/PBS, 3%
hydrogen peroxide, and 1% BSA/5% donkey serum/PBS. With inter-
spersed washes in PBS, Tks5/Fish detection was procured using a poly-
clonal antibody to the first SH3 domain of Tks5/Fish (D7771) at 1:100 dilu-
tion in 5% donkey serum/PBS for overnight at 4°C, a biotinylated anti-rabbit
secondary antibody (Santa Cruz) at 1:100 dilution in 5% donkey serum/
PBS for 1 hr at room temperature, and an HRP-conjugated anti-biotin terti-
ary antibody (Vectastain, Vector Laboratories) used according to manufac-
turer guidelines. Slides were developed using 3,3# diaminobenzidine as
substrate (DAB Substrate Kit, Vector Laboratories) according to manufac-
turer’s guidelines. Alternatively, slides were stained with hematoxylin and
eosin. Images were obtained using an Eclipse E600 bright field microscope
(Nikon) and were digitally captured using Spot Advanced 4.0.4 software
(Diagnostics Instruments).
Zymography
100,000 cells (counted by automation; Beckman) in 2 ml of DMEM contain-
ing 10% FCS were placed in single wells of a 6-well dish and grown to 80%
confluency. Cells were washed 2 times in 2 ml PBS and then incubated
with 2 ml Opti-MEM for 48 hr. Conditioned medium was collected from the
cells, filtered at 0.2 m, and diluted with zymogram sample buffer (Bio-
Rad). Samples were analyzed on 10% acrylamide/gelatin Criterion gels163
A R T I C L E(Bio-Rad). Gels were processed by stepwise treatments in renaturation
buffer for 1 hr, development buffer for overnight, Coomassie Brilliant Blue
R-250 staining solution for 1 hr, and destaining in 10% methanol/10% ace-
tic acid (Bio-Rad). The 72 kDa band is MMP2 (gelatinase A) and the 95 kDa
band is MMP9 (gelatinase B).
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